We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+25.17%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$14.8B
AUM Growth
+$1.58B
Cap. Flow
-$1.22B
Cap. Flow %
-8.22%
Top 10 Hldgs %
44.34%
Holding
132
New
32
Increased
38
Reduced
29
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 46.6%
2 Communication Services 12.82%
3 Technology 9.97%
4 Industrials 5.05%
5 Financials 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
126
DELISTED
Celgene Corp
CELG
-15,569,730
Closed -$1.55B

Similar funds

Thomas Steyer's Q4 2019 Portfolio in Review

As of Q4 2019, Thomas Steyer held 132 positions worth $14.8B, up 12% from $13.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Thomas Steyer withdrew a net $1.22B in Q4 2019, closing 16 positions and reducing 29 holdings. Its most notable exit was Celgene Corp, an estimated $1.55B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 45% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Thomas Steyer opened a new position in Salesforce worth $281M.

  • Thomas Steyer's largest Q4 2019 buy was Salesforce: 1,724,880 shares worth $281M.
  • Thomas Steyer added most to Allergan plc in Q4 2019, an estimated $317M increase.
  • Thomas Steyer's biggest Q4 2019 reduction was Broadmark Realty Capital Inc. Common Stock, cutting an estimated $754M.
  • Thomas Steyer fully exited Celgene Corp in Q4 2019, selling an estimated $1.55B.
  • Thomas Steyer's ten largest holdings make up 44% of its $14.8B portfolio in Q4 2019.
  • Thomas Steyer opened 32 new positions and closed 16 in Q4 2019.
  • Thomas Steyer's portfolio value rose 12% quarter-over-quarter to $14.8B.

Based on Farallon Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.